Possible OTC switches of erectile dysfunction drugs sildenafil and tadalafil, as well as azelastine and fluticasone propionate combination nasal sprays and migraine drug rizatriptan, are on a packed agenda for the next meeting of the German Expert Committee on Prescription.
Erectile dysfunction drugs sildenafil (25mg) and tadalafil (10mg) are among the Rx-to-OTC switches up for consideration at the next meeting of the German Expert Committee on Prescription, the SVA.
Taking place on 11 July, the meeting will also discuss the release from prescription-only status of azelastine and fluticasone propionate...
In a major milestone for the EU’s pricing and reimbursement landscape, the European Commission has published the first ever, much anticipated, joint clinical assessment report.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Weak demand for virus-blocking nasal sprays since the pandemic has left Austrian biotech Marinomed with mounting debts. The company has applied for restructuring proceedings with an Austrian court in an attempt to secure its future.
Perrigo aims its new SolpaOne high-strength paracetamol effervescent at UK pharmacists, who now have expanded powers as part of the UK government's Pharmacy First initiative.
Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.
